ELOQUA LIMITED – Trademark Portfolio
Entity Type: 03
ELOQUA LIMITED holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELOQUA. The owner is based in Redwood City, CA.
500 Oracle Parkway
Redwood City, CA 94065
Showing of trademarks Trademarks
Trademark Classifications
ELOQUA LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does ELOQUA LIMITED have?
ELOQUA LIMITED has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 cancelled.
What trademark classes does ELOQUA LIMITED file in?
ELOQUA LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ELOQUA LIMITED's most well-known trademarks?
ELOQUA LIMITED's registered trademark portfolio includes well-known marks such as ELOQUA. These are among 2 currently registered trademarks in the portfolio.
What is ELOQUA LIMITED's trademark registration success rate?
ELOQUA LIMITED has a 17% trademark registration rate, with 2 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.